We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GNTTF market cap is 386.79k. The company's latest EPS is USD -0.0178 and P/E is -0.56.
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -1.01M | -1.22M | -525k |
| Net Income | -1.64M | -1.72M | -688k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 370k | 1.94M | 1.41M |
| Total Liabilities | 213k | 87k | 39k |
| Total Equity | 157k | 1.86M | 1.37M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -740k | -1.18M | -465k |
| Investing | N/A | N/A | N/A |
| Financing | 875k | 3M | N/A |
| Market Cap | 386.79k |
| Price to Earnings Ratio | -0.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.28 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 38.68M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -63.24% |
| 52 Week High | 0.0272 |
| 52 Week Low | 0.01 |
| Spread (Intraday) | 0 (0%) |
| Company Name | GeneTether Therapeutics Inc (PK) |
| Address |
301-1665 ellis street kelowna, british columbia V1Y 2B3 |
| Website | https://www.genetether.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
